<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:"Segoe UI";
panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";
mso-believe-normal-left:yes;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><![if mso 9]><style>p.MsoNormal
{margin-left:3.0pt;}
</style><![endif]><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-CA" link="blue" vlink="purple" style="margin-left:3.0pt;margin-top:3.0pt;margin-right:3.0pt;margin-bottom:.75pt">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Keep up the awesome work, Rob!<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm">
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><b><span lang="EN-US" style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span lang="EN-US" style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> homeles_ot-l [mailto:homeles_ot-l-bounces@list.web.net]
<b>On Behalf Of </b>Rob Boyd<br>
<b>Sent:</b> June-16-16 9:35 AM<br>
<b>To:</b> Alliance<br>
<b>Subject:</b> [homeles_ot-l] Ottawa Board of Health considering motions on harm reduction and supervised injection on Monday<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">Hi Everyone,<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""> <o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">No doubt you have heard that Dr. Isra Levy is supporting an expansion of harm reduction services including supervised injection.
The Board of Health is meeting on Monday to consider key motions to protect the health and safety of some of our most vulnerable citizens.<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""> <o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">We are encouraging people to turn out to support people who use drugs who experience significant barriers to recovery due to poverty
and chronic homelessness, severe and persistent mental illness, extensive life trauma, and frequent incarceration.<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""> <o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">You can read the excellent report on the Board of Health Website. click the hyperlink to the June 20th meeting.<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""> <o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">Hope to see you on Monday! And please encourage people with lived experience to come.<o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""> <o:p></o:p></span></p>
</div>
<div>
<p class="MsoNormal" align="center" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;text-align:center">
<b><span style="font-size:20.0pt;font-family:"Arial","sans-serif";color:black">Ottawa Board of Health<br>
</span></b><b><span lang="EN-US" style="font-size:18.0pt;font-family:"Arial","sans-serif";color:black"><br>
Monday, June 20, 2016, 5:00 PM<br>
Champlain Room, 110 Laurier Avenue West</span></b><o:p></o:p></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="630" style="width:472.5pt;margin-left:5.4pt;border-collapse:collapse">
<tbody>
<tr>
<td width="630" valign="top" style="width:472.5pt;padding:0cm 5.4pt 0cm 5.4pt">
<p class="MsoNormal" style="mso-margin-top-alt:10.0pt;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:15.0pt">
<b><span lang="EN-US" style="font-family:"Arial","sans-serif"">That the Board of Health for the City of Ottawa Health Unit:</span></b><o:p></o:p></p>
<p class="MsoNormal" style="mso-margin-top-alt:10.0pt;margin-right:0cm;margin-bottom:10.0pt;margin-left:17.85pt;text-indent:-17.85pt;line-height:15.0pt">
<b><span lang="EN-US" style="font-family:"Arial","sans-serif"">1.</span></b><span lang="EN-US" style="font-size:7.0pt"> </span><b><span lang="EN-US" style="font-family:"Arial","sans-serif"">Receive for information this report, including the accompanying
technical report, outlining statistical data about problematic substance use in Ottawa, including prevention, harm reduction and treatment options as well as Supervised Injection Services (SIS) models in existence elsewhere and estimated implementation costs;</span></b><o:p></o:p></p>
<p class="MsoNormal" style="mso-margin-top-alt:10.0pt;margin-right:0cm;margin-bottom:10.0pt;margin-left:17.85pt;text-indent:-17.85pt;line-height:15.0pt">
<b><span lang="EN-US" style="font-family:"Arial","sans-serif"">2.</span></b><span lang="EN-US" style="font-size:7.0pt"> </span><b><span lang="EN-US" style="font-family:"Arial","sans-serif"">Adopt a guiding principle stating Ottawa Public Health’s support
for evidence-informed enhancements to harm reduction services, including SIS, as outlined in this report; and</span></b><o:p></o:p></p>
<p class="MsoNormal" style="mso-margin-top-alt:10.0pt;margin-right:0cm;margin-bottom:10.0pt;margin-left:17.85pt;text-indent:-17.85pt;line-height:15.0pt">
<b><span lang="EN-US" style="font-family:"Arial","sans-serif"">3.</span></b><span lang="EN-US" style="font-size:7.0pt"> </span><b><span lang="EN-US" style="font-family:"Arial","sans-serif"">Direct Ottawa Public Health staff to facilitate a consultative process
with the community, service providers and other interested stakeholders with respect to the addition of supervised injection services (SIS) as part of the various enhancements to harm reduction programming for Ottawa, as outlined in this report.</span></b><o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="mso-margin-top-alt:10.0pt;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:15.0pt">
<span lang="EN-US" style="font-size:13.5pt;font-family:"Arial","sans-serif";color:black"> </span><span style="font-size:13.5pt;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm">
<b><span style="font-family:"Arial","sans-serif""> Que le Conseil de santé de la circonscription sanitaire de la ville d’Ottawa :
<o:p></o:p></span></b></p>
<p class="MsoListParagraphCxSpFirst" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:27.75pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt">
<b><span style="font-family:"Arial","sans-serif"">1.</span></b><b><span style="font-size:7.0pt">
</span></b><b><span style="font-family:"Arial","sans-serif"">Prenne connaissance du présent rapport d’information, y compris le rapport<o:p></o:p></span></b></p>
<p class="MsoListParagraphCxSpMiddle" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:27.75pt;margin-bottom:.0001pt;mso-add-space:auto">
<b><span style="font-family:"Arial","sans-serif"">technique afférent, qui contiennent des données statistiques sur la toxicomanie à Ottawa, notamment sur la prévention, la réduction des méfaits et les options de traitement ainsi que sur les modèles de centres
d’injection supervisée (CIS) existant ailleurs dans le monde et les coûts de mise en œuvre;
<o:p></o:p></span></b></p>
<p class="MsoListParagraphCxSpMiddle" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:27.75pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt">
<b><span style="font-family:"Arial","sans-serif"">2.</span></b><b><span style="font-size:7.0pt">
</span></b><b><span style="font-family:"Arial","sans-serif"">Adopte un principe directeur exprimant le soutien de Santé publique Ottawa<o:p></o:p></span></b></p>
<p class="MsoListParagraphCxSpMiddle" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:27.75pt;margin-bottom:.0001pt;mso-add-space:auto">
<b><span style="font-family:"Arial","sans-serif"">pour des améliorations aux services de réduction des méfaits, comme les CIS, améliorations qui seraient fondées sur des données probantes et dont il est question dans le présent rapport; et
<o:p></o:p></span></b></p>
<p class="MsoListParagraphCxSpMiddle" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:0cm;margin-left:27.75pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:-18.0pt">
<b><span style="font-family:"Arial","sans-serif"">3.</span></b><b><span style="font-size:7.0pt">
</span></b><b><span style="font-family:"Arial","sans-serif"">Demande au personnel de Santé publique Ottawa d’entreprendre un
<o:p></o:p></span></b></p>
<p class="MsoListParagraphCxSpMiddle" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:27.75pt;mso-add-space:auto">
<b><span style="font-family:"Arial","sans-serif"">processus de consultation auprès des citoyens, des fournisseurs de services et des autres parties intéressées au sujet de l’ouverture de centres d’injection supervisée, dans le cadre des mesures d’amélioration
des programmes de réduction des méfaits à Ottawa, comme l’explique le rapport. </span>
</b><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""><o:p></o:p></span></p>
<p class="MsoListParagraphCxSpLast" style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:27.75pt;mso-add-space:auto">
<span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""> </span><b><span style="font-family:"Arial","sans-serif""><o:p></o:p></span></b></p>
</div>
<p class="MsoNormal" style="margin:0cm;margin-bottom:.0001pt"><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif""><o:p> </o:p></span></p>
<p><b><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">Confidentiality Notice</span></b><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">:
<o:p></o:p></span></p>
<p><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">This email message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.
<o:p></o:p></span></p>
<p><b><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">Avis de confidentialité</span></b><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">
<o:p></o:p></span></p>
<p><span style="font-size:10.0pt;font-family:"Segoe UI","sans-serif"">Les informations contenues à l’intérieur de ce courriel, y compris tous les documents qui y sont attachés, sont pour l'usage exclusif du/des destinataire(s) désignés ; car elles peuvent être
de nature confidentielle et privilégiée. N'importe quelles revue, utilisation, divulgation ou distribution non autorisée est interdite. Si vous n'êtes pas le ou les destinataire(s) désignés, veuillez immédiatement en aviser l'expéditeur par courriel et assurer
vous d’avoir détruit toutes les copies du message original. <o:p></o:p></span></p>
</div>
</body>
</html>